|
The Krogan Lab.
|
3
|
Resverlogix Corp.
|
Mar 26, 2020 06:25PM
|
|
AAT-AD/PD™ 2020.
|
4
|
Resverlogix Corp.
|
Mar 26, 2020 06:49PM
|
|
Re: BETonMACE CKD substudy abstract was supposed to be posted in AJKD
|
4
|
Resverlogix Corp.
|
Mar 26, 2020 09:06PM
|
|
#Covid19 Interview of Nevan Krogan, Director Quantitative Bioscience Institute QBI @UCSF
|
3
|
Resverlogix Corp.
|
Mar 26, 2020 11:53PM
|
|
Update on the 69.
|
7
|
Resverlogix Corp.
|
Mar 27, 2020 03:12PM
|
|
Back to the drawing board for triple-negative breast cancer targets, researchers propose new combo approach.
|
5
|
Zenith Epigenetics
|
Mar 28, 2020 06:13PM
|
|
Haven't written off a potential role for Apabetalone to play yet.
|
7
|
Resverlogix Corp.
|
Apr 01, 2020 07:18PM
|
|
Watch it before it gets moved to "Off Topic Forum" by the thought police here.
|
4
|
Zenith Epigenetics
|
Apr 04, 2020 12:29AM
|
|
Re: Shawn lu RSU and option cancelled
|
3
|
Resverlogix Corp.
|
Apr 06, 2020 02:27PM
|
|
Re: Random thoughts RVX-208 and COVID-19
|
1
|
Resverlogix Corp.
|
Apr 13, 2020 04:04PM
|
|
Re: RVX 208 and the cytokine storm syndrome
|
3
|
Resverlogix Corp.
|
Apr 20, 2020 12:20PM
|
|
Very interesting posts lately!
|
2
|
Zenith Epigenetics
|
Apr 23, 2020 01:00AM
|
|
BRIEF-Shenzhen Hepalink Pharma Gets Regulatory Approval For Hong Kong IPO.
|
1
|
Resverlogix Corp.
|
Apr 23, 2020 02:16PM
|
|
Re: BRIEF-Shenzhen Hepalink Pharma Gets Regulatory Approval For Hong Kong IPO.
|
2
|
Resverlogix Corp.
|
Apr 23, 2020 03:54PM
|
|
Re: BRIEF-Shenzhen Hepalink Pharma Gets Regulatory Approval For Hong Kong IPO.
|
4
|
Resverlogix Corp.
|
Apr 23, 2020 05:03PM
|
|
Whatever happened to the update on our trial? Stalled like everything else here.
|
3
|
Resverlogix Corp.
|
Apr 23, 2020 05:24PM
|
|
Re: Endpoints article about Pfizer and M&A
|
4
|
Zenith Epigenetics
|
Apr 29, 2020 07:53PM
|
|
Re: Is this going to become
|
4
|
Resverlogix Corp.
|
Apr 30, 2020 01:14PM
|
|
From 2018.
|
4
|
Resverlogix Corp.
|
May 02, 2020 11:30PM
|
|
SO078 APABETALONE, A BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, REDUCES ALKALINE PHOSPHATASE IN CVD PATIENTS....
|
3
|
Resverlogix Corp.
|
May 02, 2020 11:35PM
|
